NCT01025700已完成2 期
A Double-Blind Placebo Control Study on the Use of Nabilone for Outpatient Management of Acute Marijuana Withdrawal
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- Safety and tolerability to Nabilone
研究概览
简要总结
Safety of Nabilone in reducing marijuana craving
详细描述
Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 19 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •19 years or older
- •History of marijuana use
排除标准
- 未提供
研究组 & 干预措施
Cesemat
Experimental
干预措施: Cesemat (Drug)
结局指标
主要结局
Safety and tolerability to Nabilone
次要结局
- Marijuana craving questionnaire
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
1 期
Cannabis for Inflammatory Bowel DiseaseUlcerative ColitisCrohn's DiseaseNCT01040910Meir Medical Center20
已完成
2 期
A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With FibromyalgiaFibromyalgiaNCT00272207Winnipeg Regional Health Authority40
已完成
2 期
Dronabinol Treatment for Marijuana AddictionMarijuana AbuseNCT00217971New York State Psychiatric Institute156
已完成
1 期
Effects of Smoked Marijuana on Neuropathic PainNeuropathic PainNCT00254761Center for Medicinal Cannabis Research28
已完成
2 期
Randomized Double Blind Cross Over Study for Nabilone in Spasticity in Spinal Cord Injury PersonsSpasticity in Spinal Cord Injured PersonsNCT00623376University of Manitoba